PPARγ is an important transcription factor in 1α, 25-dihydroxyvitamin D3-induced involucrin expression

被引:15
作者
Dai, Xiuju [1 ]
Sayama, Koji [1 ]
Shirakata, Yuji [1 ]
Tokumaru, Sho [1 ]
Yang, Lujun [1 ]
Tohyama, Mikiko [1 ]
Hirakawa, Satoshi [1 ]
Hanakawa, Yasushi [1 ]
Hashimoto, Koji [1 ]
机构
[1] Ehime Univ, Sch Med, Dept Dermatol, Matsuyama, Ehime 790, Japan
关键词
1; alpha; 25-Dihydroxyvitamin D3; PPAR gamma; involucrin; AP-1; p38;
D O I
10.1016/j.jdermsci.2007.10.011
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: 1 alpha,25-Dihydroxyvitamin D3 (1 alpha,25(OH)(2)O-3), the active form of vitamin D, suppresses keratinocyte proliferation, promotes keratinocyte differentiation, and induces involucrin expression. Peroxisome proliferation-activated receptors (PPARs) are ligand -activated transcription factors. It has been reported that PPARs stimulate keratinocyte differentiation and regulate the expression of differentiation molecules. Objective: Keratinocytes treated with 1 alpha,25(OH)(2)D-3 induced PPAR-gamma, which was followed by increased involucrin expression. In this study, we investigated whether PPAR-gamma is involved in the 1 alpha,25(OH)(2)D-3-induced involucrin expression in human keratinocytes. Methods: Subconfluent keratinocytes were treated with 10(-7) M 1 alpha,25(OH)(2)D-3 for the indicated times, and PPAR and involucrin mRNA expression were determined by real-time RT-PCR. The levels of PPARs, involucrin, p38, and phospho-p38 proteins were assayed by Western blotting, and the DNA binding activities of PPAR gamma and AP-1 were investigated by etectrophoretic mobility shift assays (EMSA). To examine the rote of PPAR-gamma in 1 alpha,25(OH)(2)D-3 responses, recombinant adenovirus carrying a dominant-negative form of PPAR gamma (Axdn-PPAR gamma) was constructed and transfected into kerati-nocytes. The p38 inhibitor SB203580 was added to the cultures to evaluate the involvement of p38 in involucrin expression. Results: 1 alpha,25(OH)(2)D-3 induced PPAR gamma expression and stimulated PPAR gamma activity. The introduction of dn-PPAR gamma inhibited the expression of involucrin mRNA and protein induced by 1 alpha,25(OH)(2)D-3, and suppressed AP-1 DNA binding activity. 1 alpha,25(OH)(2)D-3 also triggered the phosphorylation of p38, which contributes to involucrin induction. Moreover, dn-PPAR gamma prevented the 1 alpha,25(OH)(2)D-3-induced phosphorylation of p38. Conclusions: These results suggest that PPAR gamma regulates involucrin expression by controlling the AP-1 signal and p38 activation in 1 alpha,25(OH)(2)D-3-induced keratinocyte differentiation. (C) 2007 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 23 条
[1]   The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3 [J].
Bikle, DD ;
Ng, D ;
Oda, Y ;
Hanley, K ;
Feingold, K ;
Xie, ZJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (05) :1109-1113
[2]  
DAI X, 2007, J INVEST DERMATOL, V1, P1
[3]   All-Trans-retinoic acid induces interieukin-8 via the nuclear factor-κB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes [J].
Dai, XJ ;
Yamasaki, K ;
Shirakata, Y ;
Sayama, K ;
Hashimoto, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (06) :1078-1085
[4]   Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-γ, normalizes epidermal homeostasis in a murine hyperproliferative disease model [J].
Demerjian, M ;
Man, MQ ;
Choi, EH ;
Brown, BE ;
Crumrine, D ;
Chang, S ;
Mauro, T ;
Elias, PM ;
Feingold, KR .
EXPERIMENTAL DERMATOLOGY, 2006, 15 (03) :154-160
[5]   p38 mitogen-activated protein kinases on the body surface -: A function for p38δ [J].
Eckert, RL ;
Efimova, T ;
Balasubramanian, S ;
Crish, JF ;
Bone, F ;
Dashti, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (05) :823-828
[6]   Troglitazone improves psoriasis and normalizes models of proliferative skin disease -: Ligands for peroxisome proliferator-activated receptor-γ inhibit keratinocyte proliferation [J].
Ellis, CN ;
Varani, J ;
Fisher, GJ ;
Zeigler, ME ;
Pershadsingh, HA ;
Benson, SC ;
Chi, YQ ;
Kurtz, TW .
ARCHIVES OF DERMATOLOGY, 2000, 136 (05) :609-616
[7]   Peroxisome proliferator-activated receptor-γ:: from adipogenesis to carcinogenesis [J].
Fajas, L ;
Debril, MB ;
Auwerx, J .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2001, 27 (01) :1-9
[8]   EPIDERMAL DIFFERENTIATION - THE BARE ESSENTIALS [J].
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :2807-2814
[9]   A dominant-negative peroxisome proliferator-activated receptor γ (PPARγ) mutant is a constitutive repressor and inhibits PPARγ-mediated adipogenesis [J].
Gurnell, M ;
Wentworth, JM ;
Agostini, M ;
Adams, M ;
Collingwood, TN ;
Provenzano, C ;
Browne, PO ;
Rajanayagam, O ;
Burris, TP ;
Schwabe, JW ;
Lazar, MA ;
Chatterjee, VKK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5754-5759
[10]   Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators [J].
Hanley, K ;
Kömüves, LG ;
Bass, NM ;
He, SS ;
Jiang, Y ;
Crumrine, D ;
Appel, R ;
Friedman, M ;
Bettencourt, J ;
Min, K ;
Elias, PM ;
Williams, ML ;
Feingold, KR .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :788-795